Cogent Biosciences, Inc. (COGT) short interest & options flow
NASDAQCogent Biosciences is the most pressured name among its closest biotech peers right now, and the positioning data makes the contrast stark. Short interest in COGT has reached its highest level in at least a year, with 13.1% of the free float now sold short. That compares to a broadly constructive week for correlated peers: RYTM gained 28% in a single session…
COGT retail attention surges 7.6 standard deviations above its 90-day average, ORTEX Wikipedia views data shows as of October 19.
- Market cap
- $5.49B
- Next earnings
- 9 Nov 2026
Key data as of 8 Nov 2026

Latest signals on COGT
- Alt Data
COGT retail attention surges 7.6 standard deviations above its 90-day average, ORTEX Wikipedia views data shows as of October 19.
COGT news and analysis
RSSNo long-form analysis yet for COGT. Pulse alerts and the live data picture are available on ORTEX.
Open COGT on ORTEX →Want the live picture for COGT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for COGT — free to start on ORTEX.
Sign up for free →Open COGT on ORTEX